Physician profile
James E Conway
NPI 1043356314
$272,733.17
in general payments reported to CMS, 2019-2025
24 companies · $14K in 2025
The $14K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $66K · 2021: $73K · 2022: $29K · 2023: $33K · 2024: $689 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $45K · Food and Beverage: $1,590 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $45,405.04 |
| Food and Beverage | $1,590.41 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $163,081.81 | 2019-2025 | Spira, Orthros, Ti Diagon |
| Philadelphia Medical Management Company LLC | $99,587.64 | 2019-2021 | |
| Camber Spine Technologies LLC | $5,801.32 | 2020-2022 | |
| Nevro Corp. | $2,133.16 | 2019-2024 | Senza |
| Cerapedics INC. | $538.73 | 2020-2022 | |
| Globus Medical, INC. | $426.82 | 2025 | Senza, Vyrsa V1 |
| Abbott Laboratories | $274.15 | 2019-2025 | Eterna |
| Orthofix Medical, INC. | $156.26 | 2021-2023 | Cervical-Stim, Physio-Stim, Spinal-Stim |
| Depuy Synthes Sales INC. | $131.33 | 2020 | |
| Baxter Healthcare | $107.56 | 2022-2025 | Floseal |
| Electronic Waveform Lab, INC. | $103.07 | 2022-2023 | |
| Surgalign Spine Technologies, INC. | $52.60 | 2021 | |
| Abbvie INC. | $50.46 | 2023-2024 | Botox |
| Medtronic, INC. | $46.42 | 2021-2024 | Intellis Adaptivestim |
| Ethicon US, LLC | $44.62 | 2023-2024 | Surgiflo Hemostatic Matrix, Stratafix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $39.76 | 2024 | Mild Device Kit |
| Boston Scientific Corporation | $35.98 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Abiomed | $33.66 | 2024 | Impella |
| Intrinsic Therapeutics | $22.26 | 2023 | Barricaid Acd (Annular Closure Device) |
| Biotronik Nro, INC. | $20.92 | 2023 | Biotronik |
| Vertex Pharmaceuticals Incorporated | $16.87 | 2025 | |
| Celgene Corporation | $15.16 | 2024 | Zeposia |
| Spineology INC. | $12.61 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,834.68 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.